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Severe bradycardia after hypoxaemia and 
endotracheal intubation and cardiac arrest following 
glycopyrrolate in a dog
Stefania Scarabelli, Clara Rigotti, Briony Alderson
SUMMARY
A nine-year-old neutered male Yorkshire terrier with 
history of chronic cough underwent bronchoscopy 
and bronchoalveolar lavage; general anaesthesia was 
maintained with a variable rate infusion of propofol, 
and oxygen was insufflated via a urinary catheter in 
the trachea. At the end of the procedure, desaturation 
occurred; endotracheal intubation was performed 
and was immediately followed by severe bradycardia 
and respiratory arrest. Glycopyrrolate (5 µg/kg) was 
administered leading to cardiac arrest. Apnoea and 
asystole were quickly treated with manual positive 
pressure ventilation, external chest compressions and 
intravenous administration of 0.04 mg/kg of atropine. 
This case describes vagally induced bradycardia after 
intubation, possible predisposing factors and its 
treatment/prevention with antimuscarinic drugs.
BACKGROUND
To the author’s knowledge, this is the first report 
of severe bradycardia during intubation followed 
by cardiac arrest after glycopyrrolate adminis-
tration in dogs. In veterinary medicine, vagally 
mediated arrest as an adverse effect of endo-
tracheal intubation is only briefly mentioned in 
some anaesthesiology textbooks (Dugdale 2010), 
whereas, in human medicine, bradycardia and 
asystole during laryngoscopy and tracheal intu-
bation are well-recognised complications (Jones 
2016). Due to the vagal origin of this reflex brady-
cardia, antimuscarinic drugs are commonly used as 
a treatment or prevention (Dyson and James-Da-
vies 1999, Lerche 2015). The aim of this report is 
to warn clinicians of the possible development of 
bradycardia during endotracheal intubation and to 
alert them that care should be taken when glyco-
pyrrolate is administered to counteract vagally 
mediated bradycardia.
CASE PRESENTATION
A nine-year-old, 7.2 kg, neutered male, Yorkshire 
terrier was referred for investigation of chronic 
cough. Haematology was unremarkable, biochem-
istry blood tests revealed moderately elevated urea 
(12.6 mmol/l Reference Intervals (RI): 3.5–6.0), 
alkaline phosphatase (338 U/I RI: 0–100) and 
cholesterol (8.1 mmol/l RI: 3.2–6.5) and mild 
hyperalbuminemia (35 g/l RI: 23–31); all other 
values were within normal limits. Cardiac troponin 
I was mildly elevated (0.165 ref <0.15 ng/ml) and 
systolic blood pressure, measured by a Doppler 
flow detector, was 155 mm Hg.
A six-lead electrocardiogram (ECG) was 
performed showing sinus arrhythmia with occa-
sional premature supraventricular complexes and P 
pulmonale; P waves of variable morphology were 
also present, consistent with wandering pacemaker. 
Doppler echocardiography identified degenerative 
myxomatous mitral valve disease with no evidence 
of significant left side volume overload, cardiac 
remodelling or congestive heart failure and normal 
systolic function.
General anaesthesia was requested for thoracic 
and neck radiographs, bronchoscopy and bron-
cholaveolar lavage (BAL).
At preoperative examination, the dog was bright, 
alert and responsive, panting, heart rate (HR) was 
120 beats per minute (bpm), mucous membranes 
were pink and moist and capillary refill time was 
less than two seconds. The dog was premedicated 
with butorphanol (Dolorex; MSD Animal Health) 
0.3 mg/kg intramuscularly and acepromazine 
(ACP; Novartis) 0.02 mg/kg intramuscularly. Fifty 
minutes later, an intravenous catheter was placed in 
the right cephalic vein and neck, and thoracic radio-
graphs were taken under sedation. Radiographs 
showed a generalised bronchial pattern, particu-
larly apparent in the caudal lung lobes and tracheal 
collapse.
To perform tracheobronchoscopy and broncho-
alveolar lavage, general anaesthesia was induced 
with propofol (Vetofol 1.0 per cent; Norbrook) 
slowly to effect (total dose 2 mg/kg intravenously) 
without preoxygenation due to non-cooperation of 
the dog. Oxygen was administered at 4 l/minute via 
a dog urinary catheter inserted into the trachea and 
general anaesthesia was maintained with a variable 
rate infusion of propofol (0.4–0.56 mg/kg/minute). 
Throughout the procedure the dog was panting, HR 
was between 100 and 116 bpm, mean arterial pres-
sure (MAP), measured with an oscillometric device 
(Datex Engstrom Compact; Datex Ohmeda) was 
between 70 and 100 mm Hg and oxygen saturation 
(SpO2) was 98 per cent. Twenty-five minutes after 
induction, immediately after BAL was performed, 
SpO2 decreased to 85 per cent and crackles were 
audible on both sides at lung auscultation, mainly in 
the cranial area. To attempt to improve oxygenation, 
the urinary catheter was removed and the trachea 
was intubated with a 5.5 mm cuffed endotracheal 
tube. Immediately after tracheal intubation, apnoea 
and severe bradycardia developed; occasional 
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normal complexes could be seen on the monitor’s screen but a 
reading of the HR was unavailable (<30 bpm). Manual intermit-
tent positive pressure ventilation was immediately started at 10 
breaths per minute (brpm), HR increased to 70 bpm with sinus 
rhythm, spontaneous ventilation was resumed two minutes later 
and SpO2 was 90 per cent. Propofol infusion was stopped and 
glycopyrrolate (glycopyrronium bromide; Martindale Pharma-
ceuticals) 5 µg/kg was administered intravenously as a bolus due 
to the presence of marked sinus arrhythmia. Two minutes after 
glycopyrrolate administration, a sudden cardiopulmonary arrest 
occurred. Cardiopulmonary resuscitation (CPR) was started: 
external chest compressions (with hands positioned directly over 
the heart) and manual ventilation were applied at 120 bpm and 
10 brpm, respectively. Atropine (Atrocare 600 µg/ml; Animal-
care) 0.02 mg/kg was administered intravenously immediately 
after starting chest compressions but no response was noticed; 
therefore, two minutes later, a second dose of 0.02 mg/kg intra-
venously was administered leading to a return of sinus rhythm 
(HR of 81 bpm) in two minutes, and spontaneous ventilation 
was resumed. MAP was 84 mm Hg at the first reading after 
resuscitation and EtCO2 was 30 mm Hg. Arterial blood gas anal-
ysis, performed with the dog breathing 100 per cent of oxygen, 
showed respiratory and metabolic acidosis with severe hyper-
capnia, mild hypoxia and hyperlactatemia (Table 1). Twenty-five 
minutes postresuscitation, the dog was blinking and swallowing 
so the trachea was extubated; no blood or secretions were 
present on the endotracheal tube. The dog was recovered in the 
intensive care unit and oxygen at 3 l/minute was administered via 
nasal prongs until the dog no longer tolerated them (30 minutes). 
The dog had returned to normal behaviour after 4 hours.
DISCUSSION
In human medicine, paediatric and adult patients with high 
vagal tone are particularly at risk of bradycardia and asystole 
at tracheal intubation (Sutera and Smith 1994). There are two 
sources of vagal reflex bradycardia during intubation. The first 
occurs when hypoxia is sensed by the aortic bodies and transmits 
via an afferent branch of the vagus nerve to the medulla oblongata 
which in turn uses an efferent branch of the vagus nerve to lower 
the HR. The second source of reflex bradycardia during intuba-
tion is the manipulation of the laryngopharynx which provokes 
efferent vagal nerves activation (Jones and others 2012, Jones 
and others 2014). This bradycardia is accompanied by periph-
eral vasoconstriction with the aim of redistributing blood flow to 
the vital organs while reducing myocardial oxygen consumption 
(Jones and others 2012). This mechanism is similar to the diving 
reflex which produces bradycardia, peripheral vasoconstric-
tion and apnoea; this reflex is particularly developed in diving 
mammals but is present also in humans, particularly in infants 
(Lumb and Pearl 2010), in birds (Ludders 2015) and in dogs 
(Gandevia and others 1978).
In the veterinary literature, Mathews and others (2011) 
reported a case of cardiopulmonary arrest in a French bulldog 
after extubation and administration of hydromorphone: 
the author concluded that extubation was the more likely 
responsible for the cardiac arrest. The typical high vagal tone 
of brachycephalic dogs was considered by the author to be a 
possible predisposing factor.
The dog in this case report experienced a severe bradycardia 
immediately after tracheal intubation; although not a brachy-
cephalic dog, the ECG performed the day before anaesthesia 
showed marked sinus arrhythmia with a wandering pacemaker, 
both signs of dominance of parasympathetic tone (Moïse 1998). 
Moreover, immediately after the BAL, the SpO2 decreased to 
85 per cent revealing severe hypoxaemia (Haskins 2015) which 
may have enhanced the vagal response to intubation. Respiratory 
arrest and subsequent cardiac arrest might have developed as a 
consequence of hypoxaemia independent of intubation; however, 
the sudden onset of bradycardia immediately after endotracheal 
intubation may suggest that this was a triggering factor. At this 
point, as the HR was relatively low compared with preproce-
dure and intraprocedure values, marked sinus arrhythmia was 
still present and SpO2 was only 90 per cent, therefore, glycopy-
rrolate was administered. Two minutes later, the dog developed 
cardiac arrest. Considering the effects obtained with the admin-
istration of glycopyrrolate, the use of atropine may have been a 
better option.
Among anticholinergic drugs, atropine is the most commonly 
used to treat bradycardia following tracheal intubation in chil-
dren (Jones and others 2012, Jones and others 2014) and has 
been commonly used in dogs to treat anaesthesia-related brady-
cardia. Disadvantages of using atropine are short duration of 
action, especially if given intravenously, tachycardia and arrhyth-
mias (Richards and others 1989). In paediatric human patients, 
the use of glycopyrrolate has been suggested as a preferable 
alternative to atropine as it induces less sinus tachycardia; in fact, 
when tachycardia is too pronounced, ventricular filling is limited 
and myocardial oxygen consumption is increased (Jones 2016).
In a clinical study (Watney and others 1987) including 100 
dogs undergoing elective procedures, the effects of atropine, 
hyoscine and glycopyrrolate administered for premedication, 
together with acepromazine, were evaluated; a control group, 
not receiving antimuscarinic agents, was also included. Both 
atropine and glycopyrrolate were effective maintaining higher 
HR compared with the control group but the dogs receiving 
atropine developed more severe tachycardia than the dogs 
receiving glycopyrrolate, particularly in the time period between 
premedication and induction and during recovery phase. The 
authors concluded that the effects of glycopyrrolate were much 
more desirable than the effects of atropine. Conversely, Richards 
and others (1989) showed that the rise in HR following intra-
venous glycopyrrolate was of the same order of magnitude as 
TABLE 1: Results of arterial blood gas performed at the end of 
cardiopulmonary—cerebral resuscitation
Parameter Result Reference range Unit
pH 7.073 7.350–7.450
pCO2 82.2 34.0–40.0 mm Hg
pO2 74.6 85.0–100.0 mm Hg
cHCO3 24.0 20.0–24.0 mmol/l
BE (ecf) −6.1 −5.0–0.0 mmol/l
cSO2 86.5 90.0–100.0 per cent
Na+ 144 139–150 mmol/l
K+ 4.9 3.4–4.9 mmol/l
Ca++ 1.35 1.12–1.40 mmol/l
Cl− 117 106–127 mmol/l
cTCO2 26.5 17.0–25.0 mmol/l
AGapK 8 8–25 mmol/l
Hct 33 35–50 per cent
cHgb 11.4 12.0–17.0 g/dl
Glu 9.9 3.4–6.4 mmol/l
Lac 4.54 0.60–2.90 mmol/l
Crea 132 44–115 μmol/l
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that produced by atropine. Moreover in the latter study, both 
dogs receiving glycopyrrolate and atropine experienced the 
same degree of bradycardia and second degree atrioventricular 
blocks, mainly when low doses of drugs were used. These ‘para-
doxical’ effects after administration of anticholinergic drugs 
result from initial blockade of presynaptic peripheral postgangli-
onic M1 receptors that normally inhibit the acetylcholine (Ach) 
release. This causes a transient increase in Ach prior to the onset 
of competitive antagonism at postsynaptic M2 receptor (Lerche 
2015). Richards and others (1989) suggested caution when 
using antimuscarinics to treat bradycardia due to increased vagal 
tone as there may be further parasymphatomimesis prior to the 
desired anticholinergic effect.
In their study in 1999, Dyson and others underlined two 
important aspects about the use of glycopyrrolate in dogs. First 
of all, glycopyrrolate increases oxygen demand so its use in 
presence of hypoxia could result in significant sequelae such as 
premature ventricular contraction and cardiac arrest; secondly, 
dogs of body weight less than 10 kg are more resistant to glyco-
pyrrolate and are more likely to require higher doses (>10 µg/
kg) to reverse bradycardia. Hypoxia and the use of low-dose 
(5 µg/kg) glycopyrrolate could have contributed to cardiac arrest 
in our case.
In the past, the addition of a muscarinic anticholinergic drug to 
anaesthetic premedication for preventing harmful vagal reflexes 
(and for decreasing secretions) was mandatory in people, but with 
modern anaesthetic drugs, it is less important (Glick 2015) and 
its indiscriminate use is often not justified (Dyson and James-Da-
vies 1999, Jones and others 2012). Sutera and Smith (1994) 
suggested that preoperative predetermination of autonomic 
nervous system reflex activity may help identify patients at risk 
of developing bradycardia at anaesthesia induction/intubation; 
in these patients, a pretreatment with anticholinergic agents may 
prevent or attenuate vagal-mediated cardiac arrhythmias. In this 
case, ECG before anaesthesia was indicative of high vagal tone; 
possibly the administration of antimuscarinics in the premedica-
tion could have been beneficial. However in a recent case report 
(Jang and others 2015), glycopyrrolate 10 µg/kg administered in 
premedication was unable to prevent fentanyl-induced asystole 
in one case and to treat fentanyl-induced bradycardia in a second 
one. Although not a vagal reflex, glycopyrrolate was still unable 
to prevent this parasympathetically mediated bradycardia. 
Further studies are warranted to investigate the usefulness of 
anticholinergic drugs in premedication for dogs with previously 
diagnosed increased vagal tone.
When cardiac arrest developed, atropine was administered. 
Atropine has been widely used in patients with cardiopulmo-
nary arrest; the reported dose range for atropine in dogs and 
cats is 0.02–0.04 mg/kg intravenously (Lerche 2015) but a dose 
of 0.04 mg/kg intravenously has been recommended for CPR in 
case of asystole associated with high vagal tone (Fletcher and 
others 2012). In this case, a first dose of 0.02 mg/kg was admin-
istered, and only after the second administration a response was 
noticed; a full dose of 0.04 mg/kg intravenously should have 
been administered and should be considered the standard dose 
in case of CPR.
In human medicine, bronchoscopy and BAL are considered 
safe procedures but hypoxaemia and bradycardia are reported 
as possible complications (Milman and others 1994, Hasdiraz 
and others 2006, Gao and Cui 2014). In small animals, 
bronchoscopy and BAL are generally reported as safe proce-
dure if the animal can tolerate general anaesthesia. Oxygen 
supplementation is recommended in the perioperative period 
to prevent/treat hypoxaemia (Hawkins and others 1990). In 
small-sized patients, however, the procedure potentially carries 
a greater risk due to the increased technical challenges of 
providing oxygen during the procedure itself. In a retrospective 
study (Johnson and Drazenovich 2007) evaluating the safety 
of bronchoscopic BAL in 68 cats, complications occurred in 
38 per cent of animals; 12 of 68 cats experienced haemoglobin 
desaturation, four had prolonged anaesthetic recovery and two 
had pneumothorax; all cats, however, survived to discharge 
from the hospital.
Based on human literature, cardiac monitoring is also 
suggested during tracheal bronchoscopy in small animals 
because arrhythmias can occur, generally during oxygen desatu-
ration or during manipulation of the larynx (Roudebush 1990). 
Bronchoconstriction is another possible complication, such as 
that some clinicians advocate premedication with a broncho-
dilator before the procedure (Creevy 2009). To the authors’ 
knowledge, there are no reports of cardiac arrest after BAL or 
bronchoscopy in veterinary species.
In conclusion, severe vagal reflex bradycardia should be 
considered a possible complication after intubation in dogs, and 
care should be taken when administering low doses of glycopyr-
rolate to counteract vagally mediated bradycardia.
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